Search

everythinglearnresearchcommunity

for

Search:↓

A woman's excessive hair growth was linked to a rare case of high testosterone caused by a prolactin-producing pituitary tumor.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

Test thyroid function in all obese patients and prioritize weight loss for hormonal balance.

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

A new treatment for hair loss was tested and most participants saw their hair loss stop within 2-8 weeks, with up to 50% more hair after 4 months, and no side effects.

Hair specialists vary in testing for alopecia areata, highlighting the need for standard guidelines.

Atypical symptoms in lupus can indicate different kidney issues.

25% of premenopausal women with Type 1 diabetes have undiagnosed androgen excess disorders.

Hormones significantly influence hair growth, with conditions like hirsutism and patterned hair loss linked to hormone levels; more research is needed for full understanding.

Skin symptoms can indicate endocrine disorders and have various treatments.

Subclinical hypothyroidism in women with PCOS affects thyroid and hormone interactions but not ovary structure.

A gluten-free diet significantly improves skin and health issues in people with dermatitis herpetiformis, a skin condition linked to celiac disease.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

Surgery removed an ovarian tumor, improving her symptoms and normalizing testosterone levels.

PCOS symptoms vary by age, affecting diagnosis and treatment.

The role of antibodies in alopecia is unclear, but JAK inhibitors show promise for treatment.

Specific tests may help diagnose alopecia, but their treatment impact is unclear.

Hair loss is caused by genetics, hormones, stress, and environment, and can be managed with good nutrition, stress control, and treatments.

Inflammation and metabolic changes are linked to postpartum hair loss after a first C-section.

Premature graying and hair changes can be treated with certain peptides and possibly targeting the endocannabinoid system.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

The skin acts like an endocrine organ, producing hormones that affect various body functions and skin health, and understanding this can lead to new treatments.

Most lab tests for patients with Telogen effluvium, a type of hair loss, show no or mild abnormalities; only a few specific tests are useful.

Various substances, including cosmetic sponges, vein glue, chai tea, skincare products, and medicaments, can cause allergic contact dermatitis, and healthcare workers often react to N95 masks.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

Ayurvedic treatment improved symptoms and reduced TSH levels in a hypothyroidism patient.

Many women with hair loss also have zinc deficiency, iron depletion, or thyroid issues.

Homeopathy improved hypothyroidism symptoms in a 27-year-old woman.

Eating paradise nuts led to selenium poisoning, causing nausea, hair loss, and other symptoms in two women.

Autoimmune markers may help diagnose and manage PCOS.